Since 1857, we've been reporting on issues important to retail, community and health systems pharmacists. We proudly serve 155,000 readers.

Joined December 2010
New study finds age and physical comorbidities, not psychiatric diagnoses, drive polypharmacy in psychiatric inpatients, highlighting the need for routine deprescribing reviews. Read More: hubs.li/Q04xRsQR0
3
351
Childhood pneumonia hospitalizations fell 51% after routine PCV13, but disparities remain for at-risk, Black, and lower-income children. Pharmacists can help boost screening and vaccine completion. Read More: hubs.li/Q04xKRVV0
248
Here's why you should attend the Fall 2026 Total Pharmacy Solutions Summit, from Dorrit Trate, MHA, MBA, Nancy Lyons, BSPharm, MBA, CDCES, and keynote speaker E.J. Stoepfel, RPh, MBA-HCA. Register: hubs.li/Q04x9VsG0
176
With over 40% of primary care physicians expected to reach retirement age within the next 8 years, utilizing pharmacists to their full scope of practice is becoming an urgent necessity for health care access. Listen to the full episode here: hubs.li/Q04xKN-z0
162
Student pharmacists are transforming community health as new research shows SDOH training and student-led initiatives build clinical confidence and advance health equity. Discover their impact: hubs.li/Q04xKLZR0
249
Discover how pharmacy leaders use timing and operational cycles to drive success. Explore the "Law of Rhythm" and "Law of Gestation" in this month's episode of Dispensing Leadership. Read More: hubs.li/Q04xDNWj0 #PharmacyLeadership #Healthcare
225
New research links 1+ year of HRT to a 10% lower risk of dementia and 16% lower risk of Alzheimer’s. Pharmacists play a key role in early intervention and patient counseling. Learn More: hubs.li/Q04xDN0_0
174
AI and automation are redefining pharmacy care. TelyRx CEO Vanessa Slowey shares how predictive analytics and automated workflows help pharmacists deliver proactive, patient-focused care. Read More: hubs.li/Q04xDMpm0
1
199
FDA approves leniolisib (Joenja) for children 4 to 11 with APDS, the first targeted therapy for this age group. New tablet strengths offer earlier intervention for improved outcomes. Read More: hubs.li/Q04xDLFD0
224
When GLP-1 monotherapy is not enough in T2D, new guidelines urge clinical pharmacists to personalize treatment intensification and address access barriers. Explore the recommendations: hubs.li/Q04xx4Mg0
186
Key risk factors for long COVID after hospitalization, such as female sex, severe illness, ICU stay, incomplete vaccination, and hypertension, highlight urgent needs for pharmacist-led follow-up. Read More: hubs.li/Q04xw-l00
217
New data show Omnipod 5 users with type 1 diabetes kept a 17.9% boost in time in range and 1.14% HbA1c drop over 12 months, underscoring the pharmacist’s role in device adoption. Read More: hubs.li/Q04xwZJn0
243